AS
ADPT icon

Altshuler Shaham’s Adaptive Biotechnologies ADPT Stock Holding History

Altshuler Shaham’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-515
Closed -$15K – 438
2019
Q4 		$15K Buy
+515
New +$14.8K ﹤0.01% 280

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Altshuler Shaham's ADPT Position: Q1 2020 in Review

Altshuler Shaham sold out of Adaptive Biotechnologies (ADPT) in Q1 2020, closing a stake of 515 shares — an estimated $15K sold.

Altshuler Shaham first reported a position in ADPT in Q4 2019 and held it in 1 quarter. The position peaked at $15K in Q4 2019. 147 funds tracked by Wall St. Rank hold ADPT as of Q1 2020.

  • Altshuler Shaham reported no remaining Adaptive Biotechnologies position as of Q1 2020 after selling out during the quarter.
  • Altshuler Shaham sold 515 Adaptive Biotechnologies shares in Q1 2020, an estimated $15K.
  • Altshuler Shaham first reported a position in Adaptive Biotechnologies in Q4 2019 and held it in 1 quarter.
  • Altshuler Shaham's Adaptive Biotechnologies position peaked at $15K in Q4 2019.
  • 147 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2020.

Based on Altshuler Shaham's 13F filing for Q1 2020, filed 12 May 2020.